Santos, Sean M.
Hartman, John L. IV https://orcid.org/0000-0003-1176-6469
Funding for this research was provided by:
American Cancer Society (RSG-10-066-01-TBE)
Howard Hughes Medical Institute (P/S ECA 57005927)
National Cancer Institute (P30 CA013148)
National Institute on Aging (R01 AG043076)
Cystic Fibrosis Foundation (HARTMA16G0)
Article History
Received: 1 February 2019
Accepted: 3 September 2019
First Online: 23 October 2019
Ethics approval and consent to participate
: Not applicable
: Not applicable
: JLH has ownership in the Spectrum PhenomX, LLC, a shell company that was formed to commercialize Q-HTCP technology. The authors declare that they have no other competing interests.